News

Covalent Werner helicase inhibitor shows clinical proof-of-concept in Phase I trial
For patients with cancers harboring certain genetic defects, the first-in-class targeted therapy RO7589831, which targets the ...
Cancer research in the US is world class because of its broad base of funding − with the government pulling out, its future is uncertain
Since 1971, the US has led the world in funding cancer research and developing new treatments that have driven down death ...